Central Trust Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-68,399
Closed -$6.79M 1251
2019
Q3
$6.79M Sell
68,399
-1,956
-3% -$186K 0.38% 61
2019
Q2
$6.5M Sell
70,355
-7,273
-9% -$691K 0.37% 65
2019
Q1
$7.32M Sell
77,628
-23,435
-23% -$2.05M 0.44% 55
2018
Q4
$6.48M Sell
101,063
-1,930
-2% -$142K 0.43% 55
2018
Q3
$9.22M Buy
102,993
+1,607
+2% +$142K 0.54% 44
2018
Q2
$8.05M Sell
101,386
-1,909
-2% -$159K 0.51% 44
2018
Q1
$9.21M Sell
103,295
-3,535
-3% -$339K 0.59% 41
2017
Q4
$11.1M Sell
106,830
-5,146
-5% -$581K 0.68% 34
2017
Q3
$16.3M Buy
111,976
+3,358
+3% +$457K 1.06% 24
2017
Q2
$14.1M Buy
108,618
+7,393
+7% +$906K 0.93% 28
2017
Q1
$12.6M Buy
101,225
+1,071
+1% +$128K 0.84% 31
2016
Q4
$11.6M Sell
100,154
-2,004
-2% -$223K 0.8% 32
2016
Q3
$10.7M Buy
102,158
+5,963
+6% +$645K 0.78% 27
2016
Q2
$9.49M Sell
96,195
-831
-0.9% -$86K 0.71% 35
2016
Q1
$9.71M Buy
97,026
+4,215
+5% +$434K 0.77% 31
2015
Q4
$11.1M Buy
92,811
+1,945
+2% +$225K 0.92% 24
2015
Q3
$9.83M Buy
90,866
+278
+0.3% +$34.5K 0.86% 26
2015
Q2
$10.5M Sell
90,588
-5,050
-5% -$577K 0.82% 28
2015
Q1
$11M Sell
95,638
-682
-0.7% -$81.5K 0.89% 27
2014
Q4
$10.8M Sell
96,320
-4,690
-5% -$495K 0.88% 27
2014
Q3
$9.57M Sell
101,010
-3,661
-3% -$330K 0.76% 28
2014
Q2
$8.99M Buy
104,671
+3,035
+3% +$231K 0.71% 31
2014
Q1
$7.09M Buy
101,636
+2,566
+3% +$203K 0.59% 37
2013
Q4
$8.37M Buy
99,070
+7,030
+8% +$556K 0.7% 33
2013
Q3
$7.09M Buy
92,040
+4,224
+5% +$296K 0.64% 40
2013
Q2
$5.14M Buy
+87,816
New +$5.28M 0.49% 53

Other funds holding CELG

Central Trust Company's CELG Position: Q4 2019 in Review

Central Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 68,399 shares — an estimated $6.79M sold.

Central Trust Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $16.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Central Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Central Trust Company sold 68,399 Celgene Corp shares in Q4 2019, an estimated $6.79M.
  • Central Trust Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Central Trust Company's Celgene Corp position peaked at $16.3M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Central Trust Company's 13F filing for Q4 2019, filed 21 Jan 2020.